Posts By: Rory O'Connor

Feinstein Institute, NIH launch groundbreaking clinical trial for new lupus medication


Trial examines use of synthetic endocannabinoid mimetic with no psychotropic properties to treat lupus inflammation MANHASSET, NY – Researchers at Northwell Health’s Feinstein Institute for Medical Research are leading a nationwide National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) sponsored clinical trial testing the efficacy of a synthetic cannabinoid derivative… read more

posted in: Press Releases